Blueprint
August
25, 2017
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporate Finance
100 F
Street N.W.
Washington,
D.C. 20549
Attn:
Irene Paik
Application for
Withdrawal of Registration Statement on Form S-3 (Registration No.
333-213353)
Ladies
and Gentlemen:
Pursuant to Rule
477 promulgated under the Securities Act of 1933, as amended (the
“Securities
Act”),
CorMedix Inc. (the “Company”) hereby
respectfully requests that the Securities and Exchange Commission
consent to the withdrawal, effective as of the date hereof or at
the earliest practicable date hereafter, of its Registration
Statement on Form S-3 (File
No. 333-213353), together with all exhibits thereto, initially
filed on August 26, 2016 and amended on October 13, 2016 (the
“Registration
Statement”).
The
Company determined not to utilize, and abandoned, the Registration
Statement and believes that withdrawal of the Registration
Statement is consistent with the public interest and the protection
of investors. The Company hereby confirms that no securities have
been or will be sold pursuant to the Registration
Statement.
The
Company requests that, in accordance with Rule 457(p) under the
Securities Act, all fees paid to the Commission in connection with
the filing of the Registration Statement be credited for future
use.
Please
send copies of the written order granting withdrawal of the
Registration Statement to the undersigned, with a copy to Alexander
M. Donaldson, Esq., Wyrick Robbins Yates & Ponton LLP, 4101
Lake Boone Trail, Suite 300, Raleigh, North Carolina
27607.
If you
have any questions with respect to this matter, please contact
Alexander M. Donaldson, Esq. at (919) 781-4000.
|
|
CORMEDIX
INC.
|
|
|
|
|
|
|
|
|
By:
|
/s/
Robert
W. Cook
|
|
|
|
|
Name:
Robert
W. Cook
|
|
|
|
|
Title:
Chief
Financial Officer
|
|